NP Medical News about Smoke C-reactive protein

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

C-reactive protein as a predictor of disease in smokers and former smokers: a review
International Journal of Clinical Practice, 10/12/09

Tonstad S et al. – Assay of CRP levels may be useful in monitoring disease progression and determining risk of future cardiovascular complications. However, as this marker is also an indicator of acute inflammation and challenges to the immune system, some caution must be exercised in interpreting the available data on CRP levels in patients with different chronic comorbidities.

Exclusive Author Commentary
Serena Tonstad, 10/12/09

CRP levels are expected to decrease with smoking cessation, however, the relation between stopping smoking and CRP is still not firmly established. Other diseases confound this relationship. Even in smokers without confounding comorbidities, it may take 1 year or more before levels of CRP return to normal after cessation.

<< Previous
Behavioral Indicators of Postoperative Pain in Older Adults With...

Next >>
Update on the Management of Atrial Fibrillation in Older Adults